http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06245670-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c7159366be37ecf8a4c595cfa235a8 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
filingDate | 1993-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c593c88df9b51d04d416de1b3aa26e3 |
publicationDate | 1994-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H06245670-A |
titleOfInvention | Transgenic animals |
abstract | (57) [Summary] [Constitution] A transgenic non-human mammal characterized by having a homozygous modified xeroderma pigmentosum gene modified so that the xeroderma pigmentosum gene does not function, and trans. A method for producing a transgenic non-human mammal, characterized in that ES cells are injected into an animal embryo without removing the zona pellucida in an 8-cell stage embryo. [Effect] The transgenic animal of the present invention is useful as a carcinogenic model animal reflecting an actual human disease caused by a genetic abnormality. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009532020-A |
priorityDate | 1993-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 347.